An alternative advantageous protocol for efficient synthesis of phosphorothioate oligonucleotides utilizing phenylacetyl disulfide (PADS)

Nucleosides, Nucleotides and Nucleic Acids

Volumn 26, Issue 2, 2007, Pages 181-188

  Kumar, R Krishna ^a   Olsen, Phil ^a   Ravikumar, Vasulinga T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; DISULFIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PHENYLACETYL DISULFIDE; PYRIDINE; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; QUALITY CONTROL; ROOM TEMPERATURE; STORAGE TEMPERATURE; SULFATION;

CHROMATOGRAPHY, LIQUID; MASS SPECTROMETRY; OLIGONUCLEOTIDES; ORGANOTHIOPHOSPHORUS COMPOUNDS; PHENYLACETATES; SULFIDES;

EID: 33847057669     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770601112739     Document Type: Article

References (26)

1. (a) Beaucage, S.L.; Iyer, R.P. Advances in the synthesis of oligonucleotides by the phosphoramidite Approach. Tetrahedron 1992, 48, 2223-2311;
2. (b) Beaucage, S.L.; Iyer, R.P. Phosphoramidite derivatives and their synthetic applications. Tetrahedron 1993, 49, 1925-1963;
3. (c) Beaucage, S.L. Oligonucleotide Synthesis. In Comprehensive Natural Product Chemistry, Barton, D.H.R., Nakanishi, K., eds., Pergamon Press, New York, 1999; vol. 7.05, p. 105.
4. (a) Ravikumar, V.T.; Kumar, R.K.; Capaldi, D.C.; Turney, B.; Rentel, C.; Cole, D.L. Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: Use of I-linker to eliminate 3′-terminal phosphorothioate monoester formation. Org. Proc. Res. Dev. 2003, 7, 259-266 and references cited therein;
5. (b) Krotz, A.H.; McElroy, B.; Scozzari, A.N.; Cole, D.L; Ravikumar, V.T. Controlled detritylation of antisense oligonucleotides. Org. Proc. Res. Dev. 2003, 7, 47-52;
6. (c) Zhang, Z.; Tang, J-Y. Recent development in scale up of modified oligodeoxynucleotides. Current Op. Drug Disc. Develop. 1998, 1, 304-313 and references cited therein.
7. (a) Lima, W.F.; Wu, H.; Nichols, J.G.; Prakash, T.P.; Ravikumar, V.; Crooke, S.T. Human RNase H1 uses one tryptophan and two lysines to position the enzyme at the 3′-DNA/5′-RNA terminus of the heteroduplex substrate. J. Biol. Chem. 2003, 278, 49860-49867;
8. (b) Agrawal, S.; Iyer, R.P. Perspectives in antisense therapeutics. Pharmacol. Ther. 1997, 76, 151-160;
9. (c) Dias, N.; Stein, C.A. Antisense oligonucleotides: Basic concepts and mechanisms. Mol. Cancer Ther. 2002, 1, 347-355;
10. (d) Bennett, C.F. Efficiency of antisense oligonucleotide drug discovery. Antisense Nucleic Acid Drug Dev. 2002, 12, 215-224.
11. Altmann, K.-H.; Dean, N.; Fabbro, D.; Freier, S.; Geiger, T.; Haner, R.; Husken, D.; Martin, P.; Monia, B.; Muller, M.; Natt, F.; Nicklin, P.; Phillips, J.; Pieles, U.; Sasmor, H.; Moser, H. Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals. Chimia 1996, 50, 168-176.
12. A number of second-generation phosphorothioate oligonucleotides are in various stages of preclinical and clinical trials against APOB-100, PTP-1B, VLA4, TRPM2, survivin, STAT-3. eIF-4E, etc. for the treatment of a variety of diseases such as cancer, psoriasis, diabetes, asthma, arthritis, multiple sclerosis, etc.
13. (a) Suska, A.; Grajkowski, A.; Wilk, A.; Uznanski, B.; Blaszczyk, J.; Wieczorek, M.; Stec, W.J. Antisense oligonucleotides: Stereocontrolled synthesis of phosphorothioate oligonucleotides. Pure & Appl. Chem. 1993, 4, 707-714 and references cited therein;
14. (b) Stec, W.J.; Wilk, A. Stereocontrolled synthesis of oligo(nucleoside phosphorothioate)s. Angew. Chem. Int. Ed. Engl. 1994, 33, 709-722 and references cited therein;
15. (c) Lesnikowski, Z.J. Stereocontrolled synthesis of P-chiral analogues of oligonucleotides. Bioorg. Chem. 1993, 21, 127-155.
16. Capaldi, D.C.; Gaus, H.J.; Carty, R.L.; Moore, M.N.; Turney, B.J.; Decottignies, S.; MaArdle, J.V.; Scozzari, A.N.; Ravikumar, V.T.; Krotz, A.H. Formation of 4,4′-dimethoxytrityl-C-phosphonate oligonucleotides. Bioorg. Med. Chem. Lett. 2004, 14, 4683-4690.
17. (a) Cheruvallath, Z.S.; Kumar, R.K.; Rentel, C.; Cole, D.L.; Ravikumar, V.T. Solid phase synthesis of phosphorothioate oligonucleotides utilizing diethyldithiocarbonate disulfide (DDD) as an efficient sulfur transfer reagent. Nucleosides Nucleotides & Nucleic Acids 2003, 22, 461-468 and references cited therein.
18. (a) Cheruvallath, Z.S.; Carty, R.L.; Moore, M.N.; Capaldi, D.C.; Krotz, A.H.; Wheeler, P.D.; Turney, B.J.; Craig, S.R.; Gaus, H.J.; Scozzari, A.N.; Cole, D.L.; Ravikumar, V.T. Synthesis of antisense oligonucleotides: Replacement of 3 H-1,2-benzodithiol-3-one 1,1-dioxide (Beaucage reagent) with phenylacetyl disulfide (PADS) as efficient sulfurization reagent: From bench to bulk manufacture of active pharmaceutical ingredient. Org. Proc. Res. Dev. 2000, 4, 199-204;
19. (b) Krotz, A.H.; Gorman, D.; Mataruse, P.; Foster, C.; Godbout, J.D.; Coffin, C.C.; Scozzari, A.N. Phosphorothioate oligonucleotides with low phosphate diester content: Greater than 99.9% sulfurization efficiency with "aged" solutions of phenylacetyl disulfide (PADS). Org. Proc. Res. Dev. 2004, 8, 852-858;
20. (c) Roelen, H.C.P.F.; Kamer, P.C.J.; van den Eist, H.; van der Marel, G.A.; van Boom, J.H. A study on the use of phenylacetyl disulfide in the solid-phase synthesis of oligodeoxynucleoside phosphorothioates. Recl. Trav. Chim. Pays-Bas 1991, 110, 325-331;
21. (d) Kamer, P.C.J.; Roelen, H.C.P. F.; van den Eist, H.; van der Marel, G.A.; van Boom, J.H. An efficient approach toward the synthesis of phosphorothioate diesters via the Schonberg reaction. Tetrahedron Lett. 1989, 30, 6757-6760.
22. (a) Iyer, R.P.; Egan, W.; Regan, J.B.; Beaucage, S.L. 3 H-1,2-Benzodithiole-3-one 1,1-dioxide as an improved sulfuring reagent in the solid phase synthesis of oligodeoxyribonucleoside phosphorothioates. J. Am. Chem. Soc. 1990, 112, 1253-1254;
23. (b) Iyer, R.P.; Phillips, L.R.; Egan, W.; Regan, J.B.; Beaucage, S.L. The automated synthesis of sulfur-containing oligodeoxyribonucleotides using 3 H-1,2-benzodithiol-3-one 1,1-dioxide as a sulfur-transfer reagent. J. Org. Chem. 1990, 55, 4693-4699.
24. (a) Capaldi, D.C.; Scozzari, A.N.; Cole, D.L.; Ravikumar, V.T. Is it essential to use anhydrous acetonitrile in the manufacture of phosphorothioate oligonucleotides. Org. Process Res. Dev. 1999, 3, 485-487;
25. (b) Hayakawa, Y.; Hirata, A.; Sugimoto, J.; Kawai, R.; Sakakura, A.; Kataoka, M. Effect of molecular sieves in the liquid-phase synthesis of nucleotide via the phosphoramidite method. Tetrahedron 2001, 57, 8823-8826.
26. Capaldi, D.C.; Gaus, H.; Krotz, A.H.; Arnold, J.; Carty, R.L.; Moore, M.N.; Scozzari, A.N.; Lowery, K.; Cole, D.L.; Ravikumar, V.T. Synthesis of high-quality antisense drugs. Addition of acrylonitrile to phosphorothioate oligonucleotides: Adduct characterization and avoidance. Org. Proc. Res. Dev. 2003, 7, 832-838.